These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6789438

  • 1. [The treatment of post-transfusional hemochromatosis with chelating agents].
    Delvaux D, Andrien JM, Fillet G.
    Rev Med Liege; 1981 Jun 01; 36(11):477-80. PubMed ID: 6789438
    [No Abstract] [Full Text] [Related]

  • 2. [First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].
    Giraud P, Orsini A, Giraud F, Pinsard N.
    Arch Fr Pediatr; 1965 Apr 01; 22(4):463-8. PubMed ID: 5826583
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Blood transfusion and monitoring. Post-transfusion hemochromatosis].
    Bastion Y.
    Soins; 1996 Apr 01; (605):27-8. PubMed ID: 8716246
    [No Abstract] [Full Text] [Related]

  • 5. [Idiopathic hemochromatosis. Therapeutics].
    Pergola F.
    Presse Med (1893); 1967 May 20; 75(24):1221-2. PubMed ID: 4960744
    [No Abstract] [Full Text] [Related]

  • 6. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH, Iskandar W, Keng KL, Odang O.
    Paediatr Indones; 1969 May 20; 9(3):89-98. PubMed ID: 4981722
    [No Abstract] [Full Text] [Related]

  • 7. Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
    Nijjar PS, Vongooru H, Tamene A, Valeti U, Masri C.
    Minn Med; 2015 Jul 20; 98(7):47. PubMed ID: 26267924
    [No Abstract] [Full Text] [Related]

  • 8. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J.
    Tidsskr Nor Laegeforen; 1972 May 10; 12(13):918-22. PubMed ID: 4624035
    [No Abstract] [Full Text] [Related]

  • 9. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ, Iglesias Cubero G, Espolita Santos A, López de la Iglesia JM, Enríquez Martín J, Tomás Mauri J, López-Negrete L.
    Rev Esp Cardiol; 1985 May 10; 38(5):356-7. PubMed ID: 4081244
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F, Lessmann J.
    Arzneimittelforschung; 1969 Jun 10; 19(6):944-7. PubMed ID: 5820039
    [No Abstract] [Full Text] [Related]

  • 11. Chelation therapy for iron overload.
    Nutr Rev; 1980 May 10; 38(5):185-7. PubMed ID: 7207885
    [No Abstract] [Full Text] [Related]

  • 12. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH.
    Curr Top Hematol; 1978 May 10; 1():127-50. PubMed ID: 400529
    [No Abstract] [Full Text] [Related]

  • 13. Hemochromatosis and vitamin C.
    Herbert V.
    Ann Intern Med; 1999 Sep 21; 131(6):475-6. PubMed ID: 10498572
    [No Abstract] [Full Text] [Related]

  • 14. Chelating agents in medicine.
    Br Med J; 1971 May 01; 2(5756):270-2. PubMed ID: 4102017
    [No Abstract] [Full Text] [Related]

  • 15. Clinical uses of metal-binding drugs.
    Chenoweth MB.
    Clin Pharmacol Ther; 1968 May 01; 9(3):365-87. PubMed ID: 4984845
    [No Abstract] [Full Text] [Related]

  • 16. Advances in the use of iron-chelating agents for the treatment of iron overload.
    Modell B.
    Prog Hematol; 1979 May 01; 11():267-312. PubMed ID: 392593
    [No Abstract] [Full Text] [Related]

  • 17. [Hemochromatoses].
    Bonardi R.
    Minerva Med; 1978 Jan 28; 69(4):279-82. PubMed ID: 415262
    [No Abstract] [Full Text] [Related]

  • 18. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C, La Nasa G, Contu L, Galimberti M, Polchi P, Angelucci E, Baronciani D, Barbanti I, Muretto P, Lucarelli G.
    Bone Marrow Transplant; 1993 Jan 28; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract] [Full Text] [Related]

  • 19. Pathogenesis and management of iron overload in thalassemia.
    Hershko C.
    Haematologica; 1975 Jun 28; 60(2):241-8. PubMed ID: 808456
    [No Abstract] [Full Text] [Related]

  • 20. [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
    Spraul CW, Schicketanz C, Lang GE.
    Klin Monbl Augenheilkd; 1996 Jul 28; 209(1):31-6. PubMed ID: 8965474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.